Together, these data suggest that tumor-induced repression of cDC development results in a reduced pool of circulating pre-DCs and a subsequent reduction in recruitment of cDC1s to new sites of inflammation and impaired priming of CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.